Moderna CEO: Merck deal ‘could be a game changer’ for cancer treatment

Moderna, Merck to jointly develop cancer vaccineПодробнее

Will 2025 Be the Breakthrough Year for Cancer Vaccines?Подробнее

Moderna will apply ‘same intensity’ for cancer vaccine as it did for COVID, CEO saysПодробнее

Moderna, Merck stocks boosted amid joint cancer vaccine trialsПодробнее

Experimental cancer treatment shows promise in joint trial from Moderna and MerckПодробнее

Cancer Vaccine: Game-Changer in Cancer Treatment | Breaking NewsПодробнее

Moderna CEO Says Covid-19 Vaccine a ‘Game Changer’Подробнее

Moderna to develop a personalized cancer vaccine with MerckПодробнее

Moderna and Merck enter joint venture to develop cancer vaccineПодробнее

Merck partners with Moderna to develop a cancer vaccineПодробнее

Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in TrialПодробнее

Moderna CEO talks skin cancer vaccine: It's a big deal for melanoma patientsПодробнее

Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advancesПодробнее

Moderna CEO: 'Vaccines are one of the best investments we can make'Подробнее

mRNA: A Game-Changer in Cancer TreatmentПодробнее

Moderna CEO: COVID-19 accelerated manufacturing network by 5 yearsПодробнее

Moderna CEO Stephane Bancel on melanoma treatment development: A big day for patientsПодробнее

New cancer vaccine boosts survival rate, Moderna saysПодробнее

Moderna CEO Stéphane Bancel on promising new data for mRNA cancer vaccineПодробнее